ADA Scientific Sessions 2026 Abstract
ATR-258, a GRK2-Biased ß2AR Modulator, Mitigates Worsening of Insulin Resistance in Type 2 Diabetes after Metformin Withdrawal
By Muhammad Hamza Bokhari, Erik Rollman Waara, Jasper M. A. de Jong, Show 2 more authorsTore Bengtsson
Trial in peopleInterventions
The paper
Solna
ADA Scientific Sessions 2026 Abstract, 5 Jun 2026
Presented at ADA Scientific Sessions 2026, late-breaking 2865-LB
